You are here: Industry Insights > buy

News List

Sonnet BioTherapeutics agrees to buy Relief Therapeutics pharmaceutical-technology
August 14, 2019
Biotechnology company Sonnet BioTherapeutics has agreed to acquire all outstanding shares of Relief Therapeutics under a binding share exchange agreement with Relief Therapeutics Holding.
Permira affiliate to buy small molecule company Cambrex for $2.4bn pharmaceutical-technology
August 08, 2019
An affiliate of private equity firm Permira Funds is set to acquire small molecule company Cambrex in a deal valued at approximately $2.4bn.
Pfizer to buy Array Biopharma for $10.64 bn in cash expresspharma
June 21, 2019
Pfizer will buy Array Biopharma for $10.64 billion in cash, a deal it hopes will help make it a leader in colon cancer and build up its pipeline of oncology drugs.
Upsher-Smith to buy migraine drugs from Dr Reddy’s pharmaceutical-technology
June 19, 2019
Upsher-Smith Laboratories has signed a definitive asset purchase agreement to acquire neurology products from Dr Reddy’s Laboratories.
Merck signs $1bn deal to buy Peloton Therapeutics pharmaceutical-technology
May 23, 2019
Merck has signed a definitive agreement to acquire biopharmaceutical company Peloton Therapeutics for an upfront payment of $1.05bn.
Novartis to buy IFM Tre for up to $1.57bn pharmaceutical-technology
April 03, 2019
Novartis has agreed to acquire anti-inflammatory group IFM Tre, a subsidiary of IFM Therapeutics, in a deal worth up to $1.57bn.
Lupin scouts for acquisitions across the world biospectrumasia
November 16, 2018
Leading Indian drugmaker Lupin Pharmaceuticals is looking at US, China and Japan for company and brand acquisitions in an effort to grow globally
9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To biospace
December 25, 2017
The end of 2017 isn’t likely to include too many surprises, like today’s announcement that Roche was buying San Diego-based Ignyta for $1.7 billion.
Akorn Shareholders Approve Merger Agreement with Fresenius Kabi americanpharmaceuticalreview
July 21, 2017
Akorn announced its shareholders have voted to approve the previously announced merger agreement providing for the acquisition of Akorn by Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA.